0000899243-22-014838.txt : 20220414
0000899243-22-014838.hdr.sgml : 20220414
20220414204438
ACCESSION NUMBER: 0000899243-22-014838
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210623
FILED AS OF DATE: 20220414
DATE AS OF CHANGE: 20220414
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keresty Georgia
CENTRAL INDEX KEY: 0001773532
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37766
FILM NUMBER: 22828777
MAIL ADDRESS:
STREET 1: C/O ASPEN TECHNOLOGY, INC.
STREET 2: 20 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intellia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001652130
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 364785571
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-6200
MAIL ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-06-23
2021-06-25
0
0001652130
Intellia Therapeutics, Inc.
NTLA
0001773532
Keresty Georgia
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET; SUITE 130
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2021-06-23
4
A
0
1569
0.00
A
6524
D
Stock Option (right to buy)
83.59
2021-06-23
4
A
0
2534
0.00
A
2031-06-22
Common Stock
2534
2534
D
Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
This option was granted on June 23, 2021 with respect to 2,534 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
The Form 4/A amends and restates the original Form 4 filed on June 25, 2021 to correct the number of shares of common stock and stock options granted to the reporting person.
/s/James Basta, Attorney-In-Fact
2022-04-14